Cipta Sarana Medika Tbk. vs H.M. Sampoerna Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp65 (market cap 163.22B, 631.4K 24h volume), while H.M. Sampoerna Tbk. trades at Rp740 (market cap 84.91T, 4.38M 24h volume). The key difference: H.M. Sampoerna Tbk. is far larger — about 520.2× Cipta Sarana Medika Tbk.'s market cap, and H.M. Sampoerna Tbk. is more actively traded (4.38M versus 631.4K). Which is the better fit depends on your goals.
| DKHH | HMSP | |
|---|---|---|
Market Cap | 163.22B | 84.91T |
Volume | 631.4K | 4.38M |
Lot | 6.31K | 43.81K |
Turnover | 40.44M | 3.21B |
Average Price | 64.04 | 733.08 |
Value | 40.44M | 3.21B |
Indicative Equilibrium Price | 64 | 730 |
Indicative Equilibrium Volume | 110.6K | 6.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Hanjaya Mandala Sampoerna Tbk (the Company) was established in Indonesia on October 19, 1963 based on Notarial Deed No. 69 of Anwar Mahajudin, S.H.. The Company started its commercial operation since 1913 in Surabaya, as a home industry. In 1930, this home industry was officially organized under the name of NVBM Handel Maatschapij Sampoerna.
Read more on HMSP →